Leidos
LDOS · What the business does, what can go wrong, and how options sellers approach it
What it does
Leidos is a U.S. government contractor that provides technology, engineering and science services. Its work spans defense, intelligence, civil agencies and health programs. Customers include the Department of Defense, intelligence agencies, the Department of Homeland Security, the Federal Aviation Administration and the Department of Veterans Affairs. It also serves some state, local and international customers.
The company reports results across several business segments organized around its government, health and commercial customers.
How it makes money
Leidos earns revenue mostly by winning contracts to deliver services and solutions. Common contract types include cost-plus (the government reimburses costs plus a fee), fixed-price (Leidos keeps the savings or absorbs the overruns) and time-and-materials. Many contracts run for multiple years, which gives the company a backlog of work it can point to.
Profitability depends on contract mix, how well Leidos manages costs on fixed-price work, and how efficiently it uses its workforce.
Why investors own it
Government demand for IT modernization, cybersecurity, intelligence support and defense systems tends to be steady across economic cycles. Long contracts and recurring customers can make revenue more predictable than in many industries. Some investors also like that the company generates cash and can return it through dividends and buybacks, though neither is guaranteed.
What can go wrong
- Government budget delays, shutdowns or spending shifts can slow awards and payments.
- Contracts are often competitive, and losing a large recompete can hurt revenue.
- Losing bidders can protest awards, which can delay start dates.
- Fixed-price work can lose money if costs rise.
- Regulatory, audit and compliance requirements are heavy, and mistakes can be costly.
- Acquisitions can be hard to integrate.
What to watch
- Backlog and book-to-bill ratio
- Organic revenue growth
- Operating margin by segment
- Free cash flow and cash conversion
- Major contract awards, protests and recompetes
- Federal budget and appropriations news
- Capital deployment: debt, buybacks, dividends and acquisitions
Options income angle
Options on LDOS are generally available across many expirations and strikes, though activity is usually lighter than for mega-cap stocks, so bid-ask spreads can be wider on less popular strikes. Implied volatility tends to rise around quarterly earnings, budget and shutdown headlines, and news about large contract awards or protests.
One caution for premium sellers: a sharp earnings or contract-related move can quickly overwhelm the premium collected. Because the stock can gap on news, check the earnings date before choosing an expiration, and be prepared for the possibility of assignment on short calls or puts.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended January 2, 2026, filed February 17, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Leidos remains overwhelmingly a U.S. government contractor, with approximately 87% of total revenue coming from those contracts in fiscal 2025. Revenues were $17,174 million, up 3%, and operating income rose to $2,109 million. After year-end, the company agreed to buy Entrust for $2.4 billion in cash, which will change its debt picture.
How the business did
- Revenues rose to $17,174 million from $16,662 million, mainly on program wins and higher volumes, partly offset by the completion of certain contracts. Net income attributable to Leidos common stockholders was $1,448 million versus $1,254 million.
- Operating margin was 12.3% versus 11.0%. Operating income was $2,109 million versus $1,827 million.
- Health & Civil had a 23.7% operating margin, helped by write-ups (upward revisions to expected profit on contracts) in managed health services. Defense Systems revenues grew 7% and operating income reached $156 million versus $94 million. Commercial & International operating income was $166 million versus $104 million, partly because the prior year included write-downs on UK programs.
- Net cash provided by operating activities was $1,750 million versus $1,435 million, helped by tax benefits from the 2025 tax law. The company paid dividends of $211 million, made open market repurchases of $400 million, and spent $500 million on an accelerated share repurchase. Cash was $1,108 million and outstanding debt was $4.6 billion.
Risks specific to this company
- Government dependence: Contracts with the Department of War and the U.S. Intelligence Community were approximately 49% of revenue. Budget fights, stopgap funding measures called continuing resolutions, and shutdowns can delay awards and payments.
- Backlog may not convert: Total backlog (expected future revenue from contracts) was $49.0 billion, but only $9.7 billion was funded. The government can end contracts or skip options, so unfunded backlog may never become revenue. The company also changed its backlog policy this year to include expected task orders on certain sole source contracts.
- Fixed-price exposure: Firm-fixed-price contracts were approximately 43% of revenue. If costs run over, the company absorbs them, and the filing says this has happened before.
- New executive order: Under "Prioritizing the Warfighter in Defense Contracting," future contracts are expected to restrict stock buybacks and dividends during underperformance and tie executive pay to delivery criteria. Underperformance could also require a board-approved remediation plan within 15 days.
- Goodwill: Goodwill was 47% of total assets. A $596 million non-cash impairment charge hit in fiscal 2023 in the security products unit, which still carries $311 million of goodwill.
- Open audits: Indirect cost audits by the DCAA, the government's contract auditor, remain open for fiscal 2023 and later. Adjustments can be applied retroactively.
What management is watching
- Entrust deal and financing: The $2.4 billion cash purchase comes with a 364-day bridge loan facility of $1.4 billion. The revolving credit facility was increased from $1.0 billion to $1.5 billion on February 12, 2026.
- Strategy: Management points to its NorthStar 2030 strategy and five growth pillars, plus an enterprise transformation office using artificial intelligence and automation to improve efficiency.
- Funding: On February 3, 2026, the House passed five of the six remaining fiscal 2026 appropriations bills. The Homeland Security bill was not passed, and DHS was shut down as of February 13, 2026.
- Tax and tariffs: The company expects income tax payments to decrease by approximately $91 million in fiscal 2026 because of the 2025 tax law. It expects to recover some tariff costs through cost-plus contracts and does not expect a significant tariff impact.
- Measures: Management says it manages the business by revenue, operating income, cash flows from operations and diluted earnings per share. It also watches bookings and backlog. Net bookings were $17.5 billion versus $23.2 billion.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended October 2, 2026, filed November 3, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Leidos reported third-quarter revenues of $4,630 million, up 3.6%, and net income of $413 million, up 11.9%. Growth came mainly from the Homeland segment, which includes the Entrust acquisition, and from a lower tax rate, while the Health segment shrank. For the nine months, revenues rose 4.8% but operating income fell 3.7%.
How the business did
- Quarter and year to date: Operating income was $553 million, against $535 million a year earlier, and operating margin was 11.9% against 12.0%. For the nine months, operating income was $1,575 million against $1,636 million, and operating margin was 11.6% against 12.6%.
- Segments: Homeland revenues were $1,024 million, up 32.1%, including $142 million from Entrust. Health revenues were $1,068 million, down 11.7%, and its operating income was $240 million, down 25.9%. The filing blames reduced volumes in managed health services programs and lower related incentive fees. Intelligence & Digital operating income rose 21.3% to $171 million.
- Below the operating line: Non-operating expense, net was $71 million against $51 million, mainly from interest on the new $600 million and $800 million senior notes. The effective tax rate (income tax as a share of pre-tax profit) was 14.3% against 23.8%, due to a larger federal research tax credit and a decrease in unrecognized tax benefits.
- Cash and capital return: Operating cash flow was $523 million against $711 million in the prior-year quarter, but $1,617 million for the nine months against $1,255 million. The company paid dividends of $52 million in the quarter and made open market share repurchases of $500 million, or $766 million for the nine months. Outstanding debt was $6.0 billion, against $4.6 billion at January 2, 2026.
What management is watching
- Government funding: Federal funding is secured through December 11, 2026 under a continuing resolution, a stopgap spending law. If Congress does not pass appropriations legislation or another continuing resolution by then, a partial or full federal government shutdown would result. U.S. government contracts were approximately 83% of third-quarter revenues.
- SES Business divestiture: The sale closed on October 5, 2026. Leidos kept a 41.5% non-controlling stake in the new joint venture, and fourth-quarter revenues will be lower than they would have been without the deal.
- Backlog: Backlog, the revenue the company expects to recognize under contracts, was $49,554 million in total, against $47,656 million a year earlier, of which $11,062 million was funded. Health backlog fell to $6,318 million from $8,002 million. Net bookings were an estimated $5.5 billion in the quarter, against $5.9 billion a year earlier.
- Tariffs: The company expects to recover certain portions of higher goods costs through contractual measures and does not expect tariffs to have a significant effect on its business.
Follow LDOS in Kortex
The Kortex app shows LDOS's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.